Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2000
10/04/2000CN1057099C Novel synthetic peptide, intermediate and prodn. method thereof
10/04/2000CN1057098C Glucagon-like peptide and insulinotropin derivatives
10/04/2000CN1057097C Chimeric proteins which block complement activation
10/04/2000CN1057096C Polypeptide of protein p140 and DNAS encoding it
10/04/2000CN1057095C Novel peptides, prepn. and use thereof
10/04/2000CN1057013C Novel 1 L-2 receptor-specific human immunoglobins
10/04/2000CN1057012C Method for prod. of BCRF1 proteins as inhibitors of interferon-gamma
10/03/2000US6127598 Model with disruption of gene caused by insertion of a transgene; causes decreased level of insulin production and decreased number of insulin-producing cells; for drug screening
10/03/2000US6127535 Nucleoside triphosphates and their incorporation into oligonucleotides
10/03/2000US6127522 CRFG-1a, a target and marker for chronic renal failure
10/03/2000US6127520 Purified fragment of fodrin having n-terminus of tyrosine number 26; for suppression of glutamate uptake; for treatment of nervous system disorders
10/03/2000US6127519 Calcitonin derivatives
10/03/2000US6127391 Compounds with growth hormone releasing properties
10/03/2000US6127349 For increasing the water solubility and bioavailability of pharmaceutical agents by conjugation to phospholipids
10/03/2000US6127348 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
10/03/2000US6127341 Aminomethyl-n-(1-((2-(2-thienyl)-1-(1-carbamoyl-5 -aminopentylcarbamoyl)ethyl)-n-methylcarbamoyl)-2-(2 -napthyl)ethyl)benzamide, for example; administering to stimulate growth, milk or wool production in animals
10/03/2000US6127340 Espcecially thrombin, in which the p1-p2 natural amide linkage is replaced by another bond; inhibiting coagulation of blood in a container; treatment or prevention of thrombosis
10/03/2000US6127339 Peptide for binding thereto a low density lipoprotein
10/03/2000US6127338 Three peptides of given amino acid sequences with antihyperglycemic activity; extracts of the fruit momordica charantia
10/03/2000US6127337 Bivalent thrombin inhibitors
10/03/2000US6127336 Antibacterial and antifungal peptide
10/03/2000US6127335 Cyclic adhesion inhibitors
10/03/2000US6127334 Mixing acidic solution of insulin, zinc, and a sub-isophanic amount of protamine with an alkaline solution of a physiological buffer; where one solution contains a phenolic compound, to form suspension, leaving to form phases
10/03/2000US6127333 Conjugates useful in the treatment of prostate cancer
10/03/2000US6127332 Muteins of IFN-β
10/03/2000US6127178 Modulating apotosis in isolated cell by introducing a nucleic acid into cell, expressing nucleic acid producing polypeptide having n-terminal domain of a natural id protein, confirming modulation
10/03/2000US6127173 Nucleotide sequence for targeted cleavage of nucleic acids
10/03/2000US6127169 Non-agglutinating β-galactoside binding protein and its encoding nucleic acid
10/03/2000US6127147 Sensor histidine kinase of Staphylococcus Aureus
10/03/2000US6127146 Human fibrous protein
10/03/2000US6127143 Preparation of purified and biocompatible collagen using two proteolytic enzyme treatments and a reducing agent
10/03/2000US6127131 DNA encoding a glycine transporter and uses thereof
10/03/2000US6127126 Detection or tumors in brain cells; screening for nucleotide sequences that code mutant proteins, detecting tumors in sample
10/03/2000US6127119 Detecting nucleotide sequences with receptivity to blood vessels; incubating mixture of nucleotide sequences with blood vessels, partitioning sequences with amplified affinity, amplifying nucleotide sequences
10/03/2000US6127116 Functional DNA clone for hepatitis C virus (HCV) and uses thereof
10/03/2000US6127114 Ribozymes
10/03/2000US6126965 Cationic liposomes of dimethyldioctadecylammonium bromide, phosphatidylcholine and cholesterol with encapsulation
10/03/2000US6126945 Tumor killing effects of enterotoxins, superantigens, and related compounds
10/03/2000US6126939 Anti-inflammatory dipeptide and pharmaceutical composition thereof
10/03/2000US6126938 Administering two identical or different products each containing inducing agent for the immune response, selected from the antigen and, if the antigen is protein in nature, an expression cassette capable of expressing the antigen
10/03/2000US6126937 Clpl polypeptides, polynucleotides encoding clpl polypeptides and methods for producing such polypeptides by recombinant techniques.
10/03/2000US6126933 Methods of treating inflammatory bowel diseases by administering IL-11
10/03/2000US6126918 Screening assays to identify therapeutic agents for amyloidosis
10/03/2000US6126832 Composition for dialysis and shock treatment
10/03/2000CA2172664C Interferon solution
10/03/2000CA2079171C Cyclohexapeptidyl propanolamine compounds
10/03/2000CA2006953C Methods and compositions for treatment of pathological hydrophobic interactions in biological fluids.
10/03/2000CA2000342C Novel peptidase inhibitors
10/03/2000CA2000336C Pharmaceutical compositions comprising calcitonin for intranasal administration and a spray unit for the administration of the same
10/03/2000CA1341108C Thrombin derived polypeptides; compositions and methods for use
10/03/2000CA1341106C Conformationally stabilized cell adhesion peptides
09/2000
09/30/2000CA2302144A1 Hydroxyphenyl derivatives with hiv integrase inhibitory properties
09/30/2000CA2267657A1 Hydroxyphenyl derivatives with hiv integrase inhibitory properties
09/30/2000CA2267481A1 Critical interdependency: from the role of estrogen on breast cancer to the susceptibility of women towards hiv infection
09/28/2000WO2000057190A2 Prediction of diabetes impaired wound healing
09/28/2000WO2000057185A1 Method for detecting superantigen activity in a biological sample
09/28/2000WO2000057184A2 Screening methods based on fha domains
09/28/2000WO2000056924A2 Genomic sequence of the purh gene and purh-related biallelic markers
09/28/2000WO2000056915A1 Ispa from streptococcus pneumoniae
09/28/2000WO2000056899A1 Dsp-2 dual-specificity map kinase phosphatase
09/28/2000WO2000056896A1 Hybrid synthetase, hybrid peptide and composition containing same
09/28/2000WO2000056891A2 Human transmembrane proteins
09/28/2000WO2000056890A1 Human fgf gene and gene expression products
09/28/2000WO2000056889A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/28/2000WO2000056887A1 Katp channel
09/28/2000WO2000056886A1 MATERIALS AND METHODS RELATING TO MODULATION OF p66 EXPRESSION
09/28/2000WO2000056885A1 Protein for blocking platelet adhesion
09/28/2000WO2000056884A1 pksG
09/28/2000WO2000056883A1 49 human secreted proteins
09/28/2000WO2000056882A1 48 human secreted proteins
09/28/2000WO2000056881A1 48 human secreted proteins
09/28/2000WO2000056880A1 50 human secreted proteins
09/28/2000WO2000056879A1 TRANSFORMING GROWTH FACTOR (TFG) β SUPERFAMILY ANTAGONISTS
09/28/2000WO2000056873A1 mvaA
09/28/2000WO2000056871A2 CELLS COEXPRESSING AN AMYLOID PRECURSOR PROTEIN AND AN α-SECRETASE AND THEIR USES IN TEST METHODS AND DIAGNOSTICS
09/28/2000WO2000056866A2 Akt-3 nucleic acids, polypeptides, and uses thereof
09/28/2000WO2000056865A1 Histidine kinase
09/28/2000WO2000056864A2 Methods for altering substrate specificity of phosphoinositide-dependent-protein kinase 1 (pdk1)
09/28/2000WO2000056862A1 Human tumor necrosis factor receptor tr9
09/28/2000WO2000056773A1 Antibodies specific for cyp1b1
09/28/2000WO2000056770A1 ANTI-p53 ANTIBODIES
09/28/2000WO2000056767A1 46 human secreted proteins
09/28/2000WO2000056766A1 47 human secreted proteins
09/28/2000WO2000056765A1 48 human secreted proteins
09/28/2000WO2000056764A1 Dna molecules encoding human clax proteins and their soluble fusion proteins
09/28/2000WO2000056763A1 A novel polypeptide and its derivatives, homologues and analogues
09/28/2000WO2000056761A1 Peptides blocking response to chemical substances or thermal stimuli or nociceptor inflammation mediators and compositions containing said peptides
09/28/2000WO2000056760A1 Phenylalanine derivatives
09/28/2000WO2000056756A2 Prolactin regulatory element binding protein and uses thereof
09/28/2000WO2000056755A1 49 human secreted proteins
09/28/2000WO2000056754A1 48 human secreted proteins
09/28/2000WO2000056753A1 49 human secreted proteins
09/28/2000WO2000056752A2 Apoptosis related genes
09/28/2000WO2000056751A1 50 human secreted proteins
09/28/2000WO2000056743A1 Pharmaceutical compositions comprising metal complexes
09/28/2000WO2000056405A2 Human tumor necrosis factor receptor-like 2
09/28/2000WO2000056367A1 Hemoglobin-antioxidant conjugates
09/28/2000WO2000056363A1 Treatment of lfa-1 associated disorders with increasing doses of lfa-1 antagonist
09/28/2000WO2000056354A2 Methods of using agents that act on the epithelial sheet of a human eye
09/28/2000WO2000056353A2 A uro-genital condition treatment system
1 ... 2341 2342 2343 2344 2345 2346 2347 2348 2349 2350 2351 2352 2353 2354 2355 2356 2357 2358 2359 2360 2361 ... 3163